Nanomedicine-Based Therapeutic Strategies for Next-Generation Cancer Immunotherapy
ACS Applied Materials & Interfaces · 05.08.2026 · 18 (30) · 40158-40177
DOI: 10.1021/acsami.6c11314 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 14.07.2026. Verfasst von Brynne Shu Ni Tan und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore637371, Singapore. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Nanomedicine. Die Arbeit nennt 228 Literaturangaben. Gefördert von: National Research Foundation Singapore.
Abstract (Originalsprache)
Cancer immunotherapy has reshaped cancer treatment by enabling the immune system to recognize and eliminate tumor cells. Nevertheless, its clinical translation remains limited by suboptimal response rates, poor penetration into deep tumor tissues, and insufficient therapeutic efficacy. Cancer immunotherapy alone is often inadequate as a sole treatment modality. Nanomedicine-based therapeutic strategies, including photothermal therapy, photodynamic therapy, sonodynamic therapy, nanozyme-based therapy, and cancer vaccines, have achieved considerable recognition for cancer treatment. Upon integration with cancer immunotherapy or regulated cell death pathways, these nanomedicine-based therapeutic strategies can modulate the tumor microenvironment, enhance anticancer immune response, and overcome immunotherapy resistance. This article summarizes recent advances in nanomedicine-based therapeutic strategies, the role of cancer immunotherapy, and regulated cell death pathways. We outline the strengths and limitations of these therapeutic strategies. We also discuss how combination therapeutic strategies achieve synergistic effects, future challenges, and perspectives in developing next-generation nanomedicine platforms for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore637371, Singapore.
ORCID-Profile: Yanli Zhao
Förderung
- National Research Foundation Singapore
Zitieren
APA
Tan, B. S. N., & Zhao, Y. (2026). Nanomedicine-Based Therapeutic Strategies for Next-Generation Cancer Immunotherapy. ACS Applied Materials & Interfaces, 18(30), 40158-40177. https://doi.org/10.1021/acsami.6c11314
Vancouver
Tan BSN, Zhao Y. Nanomedicine-Based Therapeutic Strategies for Next-Generation Cancer Immunotherapy. ACS Applied Materials & Interfaces. 2026;18(30):40158-40177. doi:10.1021/acsami.6c11314
BibTeX
@article{Tan2026,
author = {Tan, Brynne Shu Ni and Zhao, Yanli},
title = {Nanomedicine-Based Therapeutic Strategies for Next-Generation Cancer Immunotherapy},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {30},
pages = {40158--40177},
doi = {10.1021/acsami.6c11314}
}
EUVIMED